JRCT ID: jRCT2080223736
Registered date:29/11/2017
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 10/12/2016 |
Target sample size | 250 |
Countries of recruitment | Japan,Asia except Japan,North America,South America,Europe,Oceania,Africa |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate Therapeutic category code : 229 Other agents affecting respiratory organs Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 229 Other agents affecting respiratory organs Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT02924688,JapicCTI-173792 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
https://glaxosmithkline.co.jp/legal/inquire3_1.html | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
https://glaxosmithkline.co.jp/legal/inquire3_1.html | |
Affiliation |